BioAdaptives, Inc.
BDPT
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 56.25% | -- | -- | -- | 357.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.25% | -- | -- | -- | 357.14% |
| Cost of Revenue | -68.18% | -- | -- | -98.67% | -89.81% |
| Gross Profit | 281.82% | -- | -- | 106.50% | 105.26% |
| SG&A Expenses | -28.43% | -19.39% | -24.64% | 332.96% | 416.27% |
| Depreciation & Amortization | 50.00% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.40% | -18.23% | -23.36% | 121.74% | 273.05% |
| Operating Income | 29.37% | 20.43% | 26.45% | -117.97% | -272.27% |
| Income Before Tax | 195.06% | 43.63% | -121.44% | -909.31% | 13.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 195.06% | 43.63% | -121.44% | -909.31% | 13.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 195.06% | 43.63% | -121.44% | -909.31% | 13.72% |
| EBIT | 29.37% | 20.43% | 26.45% | -117.97% | -272.27% |
| EBITDA | 29.78% | 20.91% | 26.89% | -116.74% | -271.60% |
| EPS Basic | 163.86% | 57.34% | -82.40% | -706.52% | 72.92% |
| Normalized Basic EPS | 156.73% | 57.35% | -89.74% | -913.79% | 69.86% |
| EPS Diluted | 102.50% | 57.34% | -82.40% | -706.52% | 67.37% |
| Normalized Diluted EPS | 102.88% | 57.35% | -89.74% | -913.79% | 69.86% |
| Average Basic Shares Outstanding | 48.87% | 32.71% | 21.39% | 24.69% | 219.28% |
| Average Diluted Shares Outstanding | 2,849.59% | 32.71% | 21.39% | 24.69% | 219.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |